flumazenil has been researched along with nordazepam in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (22.73) | 18.7374 |
| 1990's | 10 (45.45) | 18.2507 |
| 2000's | 6 (27.27) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Basile, AS; Harrison, PM; Hughes, RD; Jones, EA; Murata, Y; Pannell, L; Skolnick, P; Williams, R | 1 |
| Dickey, KM; Martin, WR; Sloan, JW; Wala, E | 1 |
| Campisi, M; Iseppi, D; Laganà, G; Stacca, R; Tassi, A | 1 |
| Hole, K; Rosland, JH | 1 |
| Appel, M; Bron, HN; Hooymans, PM; Janknegt, R | 1 |
| Fassbender, CP; Hönack, D; Löscher, W | 1 |
| Spealman, RD | 2 |
| Martin, WR; McNicholas, LF; Sloan, JW; Wala, E | 1 |
| Jing, X; Sloan, JW; Wala, EP | 2 |
| Martin, WR; Sloan, JW; Wala, EP | 1 |
| Sloan, JW; Wala, EP | 1 |
| Camaris, C; Little, D | 1 |
| Alzieu, M; Becquemont, L; Delhotal Landes, B; Guglielminotti, J; Guidet, B; Maury, E; Offenstadt, G | 1 |
| Arditti, J; Bourdon, JH; de Haro, L; Hayek-Lanthois, M; Iliadis, A; Valli, M | 1 |
| Biggio, G; Latrofa, A; Papi, G; Pisu, MG; Porcu, P; Serra, M; Trapani, G | 1 |
22 other study(ies) available for flumazenil and nordazepam
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.
Topics: Adult; Aged; Benzodiazepines; Brain Chemistry; Chromatography; Diazepam; Flumazenil; Frontal Lobe; gamma-Aminobutyric Acid; Hepatic Encephalopathy; Humans; Mass Spectrometry; Middle Aged; Nordazepam; Receptors, GABA-A; Synaptic Transmission | 1991 |
Chronic administration of and dependence on halazepam, diazepam, and nordiazepam in the dog.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Brain; Diazepam; Dogs; Dose-Response Relationship, Drug; Flumazenil; Neurologic Examination; Nordazepam; Substance Withdrawal Syndrome; Substance-Related Disorders | 1991 |
[Antagonism with flumazenil of sedation by benzodiazepine during loco-regional anesthesia].
Topics: Adult; Anesthesia, Local; Anti-Anxiety Agents; Benzodiazepines; Conscious Sedation; Female; Flumazenil; Humans; Male; Middle Aged; Nerve Block; Nordazepam | 1990 |
Benzodiazepine-induced antagonism of opioid antinociception may be abolished by spinalization or blockade of the benzodiazepine receptor.
Topics: Analgesics; Animals; Anti-Anxiety Agents; Diazepam; Flumazenil; Male; Mice; Midazolam; Morphine; Narcotics; Nordazepam; Psychomotor Performance; Reaction Time; Receptors, GABA-A; Receptors, Opioid; Skin Temperature; Spinal Cord | 1990 |
Efficacy of flumazenil in COPD patient with therapeutic diazepam levels.
Topics: Aged; Diazepam; Drug Evaluation; Flumazenil; Humans; Lung Diseases, Obstructive; Male; Nordazepam | 1989 |
Physical dependence on diazepam in the dog: precipitation of different abstinence syndromes by the benzodiazepine receptor antagonists Ro 15-1788 and ZK 93426.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Carbolines; Diazepam; Dogs; Female; Flumazenil; Nordazepam; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1989 |
Disruption of schedule-controlled behavior by Ro 15-1788 one day after acute treatment with benzodiazepines.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepinones; Chlordiazepoxide; Conditioning, Operant; Convulsants; Diazepam; Flumazenil; Male; Nordazepam; Reinforcement Schedule; Saimiri | 1986 |
Discriminative-stimulus effects of midazolam in squirrel monkeys: comparison with other drugs and antagonism by Ro 15-1788.
Topics: Animals; Azabicyclo Compounds; Barbital; Benzodiazepines; Benzodiazepinones; Buspirone; Caffeine; Chlordiazepoxide; Cinanserin; Clozapine; Conditioning, Operant; Cyproheptadine; Diazepam; Diphenhydramine; Discrimination Learning; Electroshock; Flumazenil; Male; Midazolam; Muscimol; Nordazepam; Pentobarbital; Piperazines; Pyridazines; Pyrimidines; Saimiri; Tripelennamine | 1985 |
Precipitation of abstinence in nordiazepam- and diazepam-dependent dogs.
Topics: Analysis of Variance; Animals; Diazepam; Dogs; Flumazenil; Nordazepam; Oxazepam; Pyrazoles; Seizures; Substance Withdrawal Syndrome; Substance-Related Disorders | 1988 |
Flunitrazepam and nordiazepam slowly released from silastic capsules induce physical dependence in rat.
Topics: Animals; Anti-Anxiety Agents; Antidotes; Biological Availability; Delayed-Action Preparations; Diazepam; Drug Implants; Female; Flumazenil; Flunitrazepam; Nordazepam; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Substance-Related Disorders | 1995 |
Pharmacokinetics of nordiazepam in physical dependence and precipitated abstinence in dogs.
Topics: Administration, Oral; Animals; Blood Proteins; Diazepam; Dogs; Female; Flumazenil; Hydrolysis; Injections, Intravenous; Nordazepam; Oxazepam; Protein Binding; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Flumazenil, diazepam, nordiazepam and oxazepam interactions on plasma protein binding.
Topics: Animals; Anti-Anxiety Agents; Biotransformation; Blood Proteins; Diazepam; Dogs; Drug Interactions; Flumazenil; In Vitro Techniques; Nordazepam; Oxazepam; Protein Binding | 1995 |
A fatality due to moclobemide.
Topics: Antidepressive Agents; Benzamides; Diazepam; Fatal Outcome; Female; Flumazenil; Humans; Liver; Middle Aged; Moclobemide; Nordazepam; Trifluoperazine | 1997 |
The effect of chronic benzodiazepines exposure on body weight in rats.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Body Weight; Diazepam; Dose-Response Relationship, Drug; Female; Flumazenil; Flunitrazepam; GABA Modulators; Male; Nordazepam; Oxazepam; Rats; Rats, Sprague-Dawley; Sex Factors; Time Factors; Weight Gain | 1998 |
Prolonged sedation requiring mechanical ventilation and continuous flumazenil infusion after routine doses of clorazepam for alcohol withdrawal syndrome.
Topics: Aged; Alcohol Withdrawal Seizures; Anticonvulsants; Antidotes; Bronchitis; Clorazepate Dipotassium; Coma; Fatal Outcome; Flumazenil; Humans; Infusions, Intravenous; Liver Diseases; Male; Middle Aged; Nordazepam; Pneumonia; Respiration, Artificial | 1999 |
Diazepam poisoning with one-month monitoring of diazepam and nordiazepam blood levels.
Topics: Anti-Anxiety Agents; Chromatography, High Pressure Liquid; Diazepam; Flumazenil; Humans; Male; Middle Aged; Nordazepam; Poisoning; Suicide, Attempted; Treatment Outcome | 2001 |
Binding of [3H]CB 34, a selective ligand for peripheral benzodiazepine receptors, to rat brain membranes.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Binding, Competitive; Brain; Dose-Response Relationship, Drug; Female; Flumazenil; Imidazoles; Indoleacetic Acids; Isoquinolines; Ligands; Membrane Proteins; Membranes; Nordazepam; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Tritium | 2001 |